This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Uncover websites designed to help you earn money quickly. Start making fast cash with minimal effort today.
23,092 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
What if a new AI cloud champion enters the market with big backing and bold plans? This piece breaks down how chasing...
In July’s session, AT&T surprised with subscriber growth that outweighed a revenue miss, lifting its stock and offeri...
Berkshire Hathaway ramps up buybacks and sits on a large cash cushion, while Pershing Square slips 16% year-to-date a...
A fast-growing Brazilian fintech is reshaping personal finance in Latin America. Here are three concrete reasons this...
Markets opened with relief and caution as Iran tensions complicated Trump’s bravado. Traders weigh the limits of brin...
Celsius founder Alex Mashinsky has filed to vacate a 12-year crypto fraud sentence, signaling a dramatic turn in a ca...
A single 2019 decision helped Oracle pivot from legacy database vendor to an AI-ready cloud player. This article brea...
A single-session drop in the 3X leveraged FNGU ETN trimmed a $10,000 bet to $8,392, illustrating how tech leverage ca...
XRP is navigating a critical moment as Ripple deploys AI-driven security testing across the XRP Ledger. The move aims...
CrowdStrike is approaching a stock split, but smart investors look beyond the headline. Here are three solid reasons ...
A new financing tool is speeding up reimbursements for Municipal Utility Districts in Texas, promising higher returns...